Is Profound Medical Stock a Good Investment?
Profound Medical Investment Advice | PROF |
- Examine Profound Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Profound Medical's leadership team and their track record. Good management can help Profound Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Profound Medical's business and its evolving consumer preferences.
- Compare Profound Medical's performance and market position to its competitors. Analyze how Profound Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Profound Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Profound Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Profound Medical Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Profound Medical Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Profound Medical Stock
Researching Profound Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 51.0% of the company shares are owned by institutional investors. The book value of Profound Medical was at this time reported as 2.01. The company recorded a loss per share of 1.12. Profound Medical Corp last dividend was issued on the 16th of October 2019. The entity had 1:10 split on the 16th of October 2019.
To determine if Profound Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Profound Medical's research are outlined below:
| Profound Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 10.68 M. Net Loss for the year was (27.82 M) with profit before overhead, payroll, taxes, and interest of 7.04 M. | |
| Profound Medical Corp currently holds about 46.21 M in cash with (23.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21. | |
| Profound Medical has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Bronstein, Gewirtz Grossman, LLC Is Investigating Profound Medical Corp. And Encourages Stockholders to Connect - Markets Insider |
Profound Medical Quarterly Gross Profit |
|
Profound Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Profound Medical Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Profound Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Profound Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Profound Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2017-08-23 | 2017-06-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2016-11-16 | 2016-09-30 | -0.08 | -0.1 | -0.02 | 25 | ||
2016-05-06 | 2016-03-31 | -0.07 | -0.1 | -0.03 | 42 | ||
2024-05-09 | 2024-03-31 | -0.3 | -0.26 | 0.04 | 13 | ||
2019-11-07 | 2019-09-30 | -0.38 | -0.43 | -0.05 | 13 | ||
2019-08-14 | 2019-06-30 | -0.33 | -0.38 | -0.05 | 15 | ||
2019-03-07 | 2018-12-31 | -0.45 | -0.5 | -0.05 | 11 | ||
2021-03-02 | 2020-12-31 | -0.43 | -0.49 | -0.06 | 13 |
Profound Medical Target Price Consensus
Profound target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Profound Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Strong Buy |
Most Profound analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Profound stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Profound Medical Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationProfound Medical Target Price Projection
Profound Medical's current and average target prices are 6.60 and 15.30, respectively. The current price of Profound Medical is the price at which Profound Medical Corp is currently trading. On the other hand, Profound Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Profound Medical Market Quote on 25th of March 2025
Target Price
Analyst Consensus On Profound Medical Target Price
Profound Medical Analyst Ratings
Profound Medical's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Profound Medical stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Profound Medical's financials, market performance, and future outlook by experienced professionals. Profound Medical's historical ratings below, therefore, can serve as a valuable tool for investors.Know Profound Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Profound Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Profound Medical Corp backward and forwards among themselves. Profound Medical's institutional investor refers to the entity that pools money to purchase Profound Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Royal Bank Of Canada | 2024-12-31 | 421.2 K | Ardsley Advisory Partners | 2024-12-31 | 295 K | Ring Mountain Capital, Llc | 2024-12-31 | 277.9 K | Picton Mahoney Asset Management | 2024-12-31 | 250 K | Formula Growth Ltd | 2024-12-31 | 250 K | Bank Of America Corp | 2024-12-31 | 202.6 K | Stonepine Capital Management Llc | 2024-12-31 | 200 K | Bleichroeder Lp | 2024-12-31 | 183.3 K | Thompson Davis & Co Inc | 2024-12-31 | 182.3 K | Fidelity International Ltd | 2024-12-31 | 1.8 M | Gagnon Securities Llc | 2024-12-31 | 1.7 M |
Profound Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 204.57 M.Market Cap |
|
Profound Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.40) | (0.42) | |
| Return On Capital Employed | (0.52) | (0.55) | |
| Return On Assets | (0.40) | (0.42) | |
| Return On Equity | (0.46) | (0.48) |
Determining Profound Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Profound Medical is a good buy. For example, gross profit margin measures Profound Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Profound Medical's profitability and make more informed investment decisions.
Evaluate Profound Medical's management efficiency
Profound Medical Corp has return on total asset (ROA) of (0.3619) % which means that it has lost $0.3619 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.607) %, meaning that it created substantial loss on money invested by shareholders. Profound Medical's management efficiency ratios could be used to measure how well Profound Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.42. The current Return On Capital Employed is estimated to decrease to -0.55. At this time, Profound Medical's Other Assets are most likely to increase significantly in the upcoming years. The Profound Medical's current Fixed Asset Turnover is estimated to increase to 13.66, while Total Assets are projected to decrease to roughly 49.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.44 | 3.43 | |
| Tangible Book Value Per Share | 2.43 | 3.15 | |
| Enterprise Value Over EBITDA | (4.24) | (4.45) | |
| Price Book Value Ratio | 3.08 | 3.42 | |
| Enterprise Value Multiple | (4.24) | (4.45) | |
| Price Fair Value | 3.08 | 3.42 | |
| Enterprise Value | 136.1 M | 197.4 M |
The management team at Profound Medical has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Beta 0.771 |
Basic technical analysis of Profound Stock
As of the 25th of March, Profound Medical holds the Variance of 7.08, coefficient of variation of (5,355), and Risk Adjusted Performance of (0.01). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Profound Medical, as well as the relationship between them. Please check Profound Medical Corp market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Profound Medical Corp is priced some-what accurately, providing market reflects its current price of 6.6 per share. Given that Profound Medical has information ratio of (0.01), we recommend you to check out Profound Medical Corp's recent market performance to make sure the company can sustain itself at a future point.Profound Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Profound Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Profound Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Profound Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hofer Michael over three months ago Acquisition by Hofer Michael of 500000 shares of Profound Medical at 0.0014 subject to Rule 16b-3 |
Profound Medical's Outstanding Corporate Bonds
Profound Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Profound Medical Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Profound bonds can be classified according to their maturity, which is the date when Profound Medical Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand Profound Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Profound Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.2108 | |||
| Mean Deviation | 2.06 | |||
| Coefficient Of Variation | (5,355) | |||
| Standard Deviation | 2.66 | |||
| Variance | 7.08 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | 0.0479 | |||
| Treynor Ratio | 0.2008 | |||
| Maximum Drawdown | 12.42 | |||
| Value At Risk | (4.57) | |||
| Potential Upside | 5.08 | |||
| Skewness | 0.4172 | |||
| Kurtosis | 0.2551 |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.2108 | |||
| Mean Deviation | 2.06 | |||
| Coefficient Of Variation | (5,355) | |||
| Standard Deviation | 2.66 | |||
| Variance | 7.08 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | 0.0479 | |||
| Treynor Ratio | 0.2008 | |||
| Maximum Drawdown | 12.42 | |||
| Value At Risk | (4.57) | |||
| Potential Upside | 5.08 | |||
| Skewness | 0.4172 | |||
| Kurtosis | 0.2551 |
Consider Profound Medical's intraday indicators
Profound Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Profound Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 6.6 | |||
| Day Typical Price | 6.6 | |||
| Price Action Indicator | (0.10) | |||
| Period Momentum Indicator | (0.21) | |||
| Relative Strength Index | 49.99 |
Profound Medical Corporate Filings
| 10th of March 2025 Other Reports | ViewVerify | |
8K | 7th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 23rd of January 2025 Other Reports | ViewVerify | |
6K | 6th of January 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
Profound Stock media impact
Far too much social signal, news, headlines, and media speculation about Profound Medical that are available to investors today. That information is available publicly through Profound media outlets and privately through word of mouth or via Profound internal channels. However, regardless of the origin, that massive amount of Profound data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Profound Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Profound Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Profound Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Profound Medical alpha.
Profound Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Profound Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Profound Medical Corporate Management
| Arun MBA | Chairman CEO | Profile | |
| Hartmut Warnken | Senior Alliances | Profile | |
| Jacques Cornet | Senior Sonalleve | Profile | |
| Stephen Kilmer | Investor Relations | Profile | |
| Mathieu Burtnyk | Senior TULSAPRO | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Abbey Goodman | Chief Global | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share | Quarterly Revenue Growth 0.844 | Return On Assets | Return On Equity |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Profound Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.